Hi everyone,
Currently I am working on a research project in the Netherlands, while studying Pharmacy.
My study consists of 2 groups of different sizes. group 1: 50 patients (patients using the drug metformin) and group 2: 100 patients (control group, non diabetic).
I want to investigate if there is a significant difference in uptake of a radioactive pharmacon in the intestines. Next I also want to investigated is metformin discontinuation period and metformin dosage influence the uptake within the metformin group.
The characteristics BMI, age, sex and blood glucose differ between group 1 and group 2. I thought I could make a correction for these possible confounders but I am not sure.
Someone out there who can help me?
Thanks!
Currently I am working on a research project in the Netherlands, while studying Pharmacy.
My study consists of 2 groups of different sizes. group 1: 50 patients (patients using the drug metformin) and group 2: 100 patients (control group, non diabetic).
I want to investigate if there is a significant difference in uptake of a radioactive pharmacon in the intestines. Next I also want to investigated is metformin discontinuation period and metformin dosage influence the uptake within the metformin group.
The characteristics BMI, age, sex and blood glucose differ between group 1 and group 2. I thought I could make a correction for these possible confounders but I am not sure.
Someone out there who can help me?
Thanks!